Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC Followed by Weekly Docetaxel as Neoadjuvant Treatment for Breast Cancer
NCT00129376Phase 2Completed
- Sponsor
- GEICAM
- Start
- Feb 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by GEICAM. Started Feb 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00129376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129376.